COVID-19

The CDC updated its guidance due to the United States seeing fewer hospitalizations associated with COVID-19 and because there are numerous tools to combat influenza, COVID-19, and respiratory syncytial...

Individuals with HIV are at higher risk of severe disease from COVID-19. In a recent study, researchers aimed to examine the factors that influence COVID-19 vaccine uptake in this patient population.

This COVID-19 roundup includes coverage of the FDA’s guidance for the correct Moderna vaccine dosage for pediatric patients, COVID-19 outcomes for patients with hypertension and diabetes, and the risk of...

Researchers studied the risk and prevalence of individuals developing varicella-zoster reactivation after receiving mRNA COVID-19 vaccination compared with receiving influenza vaccination. Their findings...

Researchers aimed to quantify the amount of protection maternal COVID-19 boosters provide during the first 6 months of an infant’s life.

In a prospective study, researchers evaluated the immune response and adverse events of COVID-19 and seasonal influenza vaccine coadministration.

This COVID-19 roundup includes coverage on the outcomes associated with two omicron subvariant treatments, FDA’s authorization of Novavax vaccine, the NIH Treatment Guidelines Panel’s recommendation of...

This COVID-19 roundup includes coverage on the FDA-approved oral antiviral treatment for adults with mild-to-moderate COVID-19, how antidepressant medication may lower the incidence of COVID-19, a study...

The FDA approved the new round of vaccines for those 12 years and older and authorized emergency use for children 6 months to 11 years of age.

The FDA approved the new round of vaccines for those 12 years and older and authorized emergency use for children 6 months to 11 years of age.